obesity

WHO issues first-ever global guideline on GLP-1 weight-loss drugs to address the obesity crisis

WHO has issued its first global guideline supporting the use of GLP-1 weight-loss medicines for long-term obesity care, calling obesity…

December 2, 2025 13:01 IST

What is Ozempic 2.0? Three things to know about the new obesity drug

A new wave of weight-loss pills, dubbed Ozempic 2.0, promises easier daily dosing, strong results and wider access, with FDA…

November 28, 2025 17:50 IST

Anti-Obesity Day: Why two people eating the same meal gain weight differently? Doctor explains the real reason

Anti-Obesity Day: Why do two people eat the same meal but only one gains weight? Doctors say the answer isn’t…

Updated: November 29, 2025 13:39 IST

Novo Nordisk stock plunges to a four-year-low. Here is the reason behind the slump

Novo Nordisk shares plunge after semaglutide Alzheimer’s trial fails to meet its main goal, deepening pressure amid competition, leadership shifts…

November 24, 2025 21:08 IST

Novo Nordisk joins hands with Emcure Pharma to launch Poviztra, a semaglutide-based weight loss drug, in India. (Source: Freepik)

Novo Nordisk partners Emcure Pharma to commercialise weight loss drug Poviztra in India

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about…

Updated: November 10, 2025 12:55 IST

The silent health crisis that can eat into the savings of Indian households

The World Obesity Federation estimates obesity-related costs borne by India in 2019 at nearly $29 billion which represented 1 per…

October 3, 2025 17:53 IST

India’s next big health crisis: UNICEF report unveils shocking obesity-related trends

UNICEF’s study further warns that these weight and nutrition-related health problems can increase the risk of individuals catching cardiovascular diseases,…

September 27, 2025 21:54 IST

WHO’s new guidelines support weight-loss drugs from Novo Nordisk, Eli Lilly to treat obesity

WHO is set to recommend weight-loss drugs like Wegovy, Ozempic, and Mounjaro for adults with obesity, calling it a serious…

September 17, 2025 14:34 IST

The world is becoming a hotter place. The rising temperatures are prompting Americans to consume more liquid sugars in the form of ice creams and sweetened beverages, a new study finds.

Why Americans are eating more sugar and how it’s linked to climate change

Global warming, which has increased temperatures worldwide, is prompting people to consume more liquid sugars, including sweetened beverages and soda.…

September 11, 2025 11:52 IST

Obesity overtakes underweight in kids worldwide, UNICEF urges urgent action

UNICEF warns childhood obesity has overtaken underweight globally, with 188 million children affected. Experts blame unhealthy food environments and aggressive…

September 10, 2025 16:10 IST

WHO updates essential medicines lists with new treatments for cancer, diabetes, obesity, and more

WHO has updated its Essential Medicines Lists, adding new cancer, diabetes, obesity, and cystic fibrosis treatments, aiming to improve global…

Updated: September 9, 2025 18:59 IST

Why diabetes is affecting young people: Chronic stress is an important contributor for diabetes, as stress disrupts insulin regulation. Here are other risk factors for early onset diabetes

20 and diabetic? 10 reasons why diabetes is rising among young adults

Stress, pollution or sedentary lifestyle? Here are reasons why young people in their twenties are getting diagnosed with type 2…

September 4, 2025 15:56 IST

GST reduction snacks impact obesity: Pasta, noodles, namkeen to get cheaper

Pasta, noodles, namkeen to get cheaper: Will GST 2.0 reforms make India more obese? What experts say

GST 2025 food tax slab: Health experts say that while GST 2.0 is a welcome reform for making everyday items…

Updated: September 15, 2025 14:55 IST

Eli Lilly launches Mounjaro KwikPen for diabetic and obese patients in India – Check doses, prices and how it works

Eli Lilly launches Mounjaro KwikPen in India, offering adults with type 2 diabetes and obesity a once-weekly, prescription-only treatment.

Updated: August 13, 2025 15:12 IST

New Hope for Obesity & Diabetes, But Affordability and Lifestyle Changes Remain Key. (Image Source: Pixabay)

Weight-loss drugs may not solve India’s obesity problem

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly’s Mounjaro has received regulatory approval, introducing powerful…

June 27, 2025 22:10 IST

Wegovy now available in India: Doctors explain cost, who should take it and key side effects

Wegovy, a weekly weight-loss injection by Novo Nordisk, has launched in India. Priced from Rs 17,000/month, it helps users lose…

June 25, 2025 17:16 IST

Novo Nordisk gearing up for pan-India launch of Wegovy, eyes Rs 8,600 crore in sales.

Novo Nordisk eyes Rs 8,600 crore India sales with weight-loss drug Wegovy

Novo Nordisk is planning a major India launch of its blockbuster weight-loss drug Wegovy, aiming for Rs 8,600 crore in…

Updated: June 24, 2025 19:07 IST

Not Delhi or Mumbai but THIS is the most obese Indian state; nearly 50% population affected

A new study analyzing NFHS-5 data reveals India’s most obese state. With alarming obesity rates across cities, experts warn this…

June 23, 2025 18:45 IST

Related News

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zukerberg to lead Meta superintelligence labs

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs

Meet Jeetu Patel: Indian-origin Cisco executive who works 18 hours a day but follows 2 simple rules for work–life balance

H-1B, H-1B tax rules, US tax laws, H-1B visa, H-1B resident status, H-1B taxation, Substantial Presence Test

How are H-1B visa holders taxed in America?

Budget 2026: Even with 80% taxpayers in new tax regime, why the old tax regime may still stay

Budget 2026: Old tax regime to be scrapped as 80% taxpayers already moved to new regime? What experts have to say

Pawan Kumar Chandana is an IIT Kharagpur alumnus who worked at ISRO for five years before founding his own aerospace company, Skyroot Aerospace, where he currently serves as CEO.

Pawan Kumar Chandana – How a Vizag boy who scored 51 in maths built India’s largest private rocket factory

Pilot bodies warn against dilution of safety norms

Business20 min ago

ALPA warns DGCA against compromising safety for commercial pressures, urges withdrawal of waivers granted to IndiGo. The association reminds the regulator that safety cannot be weighed against commercial pressures and calls for investigation into whether a pilot scarcity narrative is being created to weaken the rules.

View all shorts